Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Rapid activation of ARF6 after RAF inhibition augments BRAFV600E and promotes therapy resistance.
Journal: Oncogene
Published: August 08, 2025
Dasatinib resensitizes BRAF/MEK inhibitor efficacy in patient-derived xenografts from patients with progression on BRAF/MEK inhibitor treatment.
Journal: iScience
Published: May 07, 2025
Oxidative Phosphorylation (OXPHOS) Promotes the Formation and Growth of Melanoma Lung and Brain Metastases.
Journal: bioRxiv : the preprint server for biology
Published: February 03, 2025
Integrated analysis of molecular and clinical features associated with overall survival in melanoma patients with brain metastasis.
Journal: Acta neuropathologica communications
Published: November 24, 2024
Unveiling the Expected: A Case Report of a Massive Congenital Lung Cyst in a 22-Year-Old Male.
Journal: Cureus
Published: July 23, 2024
Tumour-intrinsic endomembrane trafficking by ARF6 shapes an immunosuppressive microenvironment that drives melanomagenesis and response to checkpoint blockade therapy.
Journal: Nature communications
Published: January 04, 2024
ARF6-dependent endocytic trafficking of the Interferon-γ receptor drives adaptive immune resistance in cancer.
Journal: bioRxiv : the preprint server for biology
Published: October 24, 2023
Loss of AMPKα2 promotes melanoma tumor growth and brain metastasis.
Journal: iScience
Published: February 21, 2023
Dasatinib Resensitizes MAPK Inhibitor Efficacy in Standard-of-Care Relapsed Melanomas.
Journal: bioRxiv : the preprint server for biology
Published: January 30, 2023
Combined inhibition of HMGCoA reductase and mitochondrial complex I induces tumor regression of BRAF inhibitor-resistant melanomas.
Journal: Cancer & metabolism
Published: August 17, 2021
Mechanism-Specific Pharmacodynamics of a Novel Complex-I Inhibitor Quantified by Imaging Reversal of Consumptive Hypoxia with [18F]FAZA PET In Vivo.
Journal: Cells
Published: October 30, 2019
Increased Tumor Glycolysis Characterizes Immune Resistance to Adoptive T Cell Therapy.
Journal: Cell metabolism
Published: July 22, 2017
Last Updated: 09/26/2026